# HEMISPHERX BIOPHARMA INC (HEB)

> Institutional ownership reported to the SEC as of Q2 2019, from Form 13F filings. Source: https://holderbook.com/stocks/HEB/

- Reporting holders: 5
- Reported value: $362.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [SABBY MANAGEMENT, LLC](https://holderbook.com/funds/1535610-sabby-management-llc/) | $267.0K | 60,858 | 0.3% | 1 |
| [BlackRock Inc.](https://holderbook.com/funds/1364742-blackrock-inc/) | $46.0K | 10,526 | 0.0% | 1 |
| [A.R.T. Advisors, LLC](https://holderbook.com/funds/1315281-a-r-t-advisors-llc/) | $44.0K | 10,022 | 0.0% | 1 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $4.0K | 847 | 0.0% | 1 |
| [American Portfolios Advisors](https://holderbook.com/funds/1961150-american-portfolios-advisors/) | $1.0K | 228 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2019 | 5 | $362.0K |
| Q1 2019 | 10 | $192.0K |
| Q4 2018 | 12 | $261.0K |